Author: Hoff Communications
MSAA Debuts New Logo and Website Design
The Multiple Sclerosis Association of America (MSAA) is pleased to introduce our new logo and redesigned website homepage! As we enter our 50th year of dedicated service to the MS […]
Read News ArticleWhat is Multiple Sclerosis?
Multiple sclerosis (MS) is a disease of the central nervous system (CNS), which consists of the brain, optic nerves, and spinal cord. It is an unpredictable disorder that can cause […]
Read News ArticleWhat We Do
MSAA improves lives today for the multiple sclerosis (MS) community through our free programs and services. Learn more about what we offer and how to access these vital resources. Toll-Free […]
Read News ArticleHelpline FAQs
What services are offered through MSAA’s Helpline? MSAA provides a toll-free Helpline that allows individuals with MS, family members, care partners, and friends to speak directly with one of MSAA’s […]
Read News ArticleMSAA Announces New Chairperson of Healthcare Advisory Council
The Multiple Sclerosis Association of America (MSAA) is proud to announce the new Chairperson of the Healthcare Advisory Council for the organization. Dr. Carrie Hersh, a multiple sclerosis specialist at […]
Read News ArticleWho We Are
MSAA’s Mission and Overview MSAA… Improving Lives Today! The Multiple Sclerosis Association of America (MSAA) is a leading resource for the entire MS community, improving lives today through vital services […]
Read News ArticleFDA Approves Generic Versions of Gilenya®
On December 5, 2019, the United States Food and Drug Administration (FDA) announced that they had approved the applications from three separate pharmaceutical companies for the first generic versions of Gilenya® (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients.
Read News ArticleWhat’s New in MS Research: November 2019
This edition of MSAA’s “What’s New in MS Research” provides highlights from this year’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting. Experts from throughout the world gathered in Stockholm, Sweden in mid-September to share and discuss the latest research into the causes, diagnosis, course, and treatment of multiple sclerosis.
Read News ArticleMSAA’s Magazine, The Motivator, Wins a 2019 National Health Information Award
The Multiple Sclerosis Association of America (MSAA) is pleased to announce that we have received an award from the 26th Annual National Health Information Awards! Each year, the National Health […]
Read News Article